Early access program

Join our team of partners and collaborators

CellPly is actively working with early collaborators and early access partners as biopharma companies, research institutes and service providers involved in the development of breakthrough cell and gene therapies.

Early access partners are limited to a small handful. These partners will have access to the technology prior to our formal launch and gain the benefits of its utility ahead of the market.

If you wish to have access to this exciting technology as an early access customer, please contact us.